Skip to main content
. 2021 Feb 24;17:1744806921999013. doi: 10.1177/1744806921999013

Table 2.

Pearson correlation coefficients (R), percentage of genes changed by the pain state relative to naïve (%Cp), percentage of genes recovered by SCS (%RSCS) and percentage of genes that ended near naïve levels upon SCS treatment (%Dn) for each cell-specific transcriptome.

Genes %Cpa. R %R
SCSb.
%D
nc.
DTMP HRP LRP DTMP HRP LRP DTMP HRP LRP
Resting 1569 38% (↑49% ↓51%) 0.65* 0.42* 0.39* 83% 70% 59% 68% 50% 46%
Post-injury 3706 33% (↑61% ↓39%) 0.65* 0.47* 0.17* 84% 75% 53% 61% 52% 41%
Inflammatory (CAIA) 119 24% 83% 79% 72% 66% 66% 55%
Inflammatory (LPS) 2100 36% 84% 76% 48% 57% 49% 36%
Ischemia 1955 31% 85% 72% 56% 65% 53% 44%
Neuroprotective/repopulating 1588 58% (↑47% ↓53%) 0.58* 0.48* 0.17* 76% 70% 56% 53% 44% 38%
Neurodegeneration 90 66% 85% 88% 19% 39% 42% 8%
TBI 1491 57% 75% 68% 58% 53% 44% 39%
Systematic review 20 45% 89% 89% 78% 67% 44% 44%

a% of genes with expression level changes of at least 10% by the pain model relative to naive (%C ≥ 10%); ↑ = increased, ↓ = decreased.

b% of genes that returned toward naive levels upon treatment (Rf ≤ 1).

c% of genes that returned to within 15% of the expression level in naïve animals upon treatment (%CSCS ≤ 15%).

*Denotes significant (p < 0.05) correlations between naïve and each treatment.